|
US7393682B1
(en)
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
|
PT698094E
(pt)
|
1993-05-12 |
2004-05-31 |
Inst Genetics Llc |
Composicoes de bmp-11
|
|
DE69534468T2
(de)
|
1994-07-08 |
2006-07-13 |
The Johns Hopkins University School Of Medicine |
Wachstums-differenzierungsfaktor-11
|
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
|
US6008434A
(en)
|
1994-07-08 |
1999-12-28 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-11 transgenic mice
|
|
AU742663B2
(en)
|
1997-05-30 |
2002-01-10 |
Stryker Corporation |
Methods for evaluating tissue morphogenesis and activity
|
|
US6656475B1
(en)
|
1997-08-01 |
2003-12-02 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
|
|
US6891082B2
(en)
*
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
|
US6696260B1
(en)
|
1997-08-01 |
2004-02-24 |
The Johns Hopkins University School Of Medicine |
Methods to identify growth differentiation factor (GDF) binding proteins
|
|
US7795202B2
(en)
|
1997-08-04 |
2010-09-14 |
Neurorepair, Inc. |
Methods for treating a neurological disorder by peripheral administration of a transforming growth factor alpha (TGF-a)
|
|
US6953662B2
(en)
|
1997-08-29 |
2005-10-11 |
Human Genome Sciences, Inc. |
Follistatin-3
|
|
AU1276399A
(en)
|
1997-11-07 |
1999-05-31 |
Genetics Institute Inc. |
Neuronal uses of bmp-11
|
|
US20030170213A1
(en)
|
1998-01-23 |
2003-09-11 |
Marc F. Charette |
Methods and compositions for enhancing cognitive function using morphogenic proteins
|
|
DE69940022D1
(de)
|
1998-07-15 |
2009-01-15 |
Metamorphix Inc |
Promotoren für wachstums-differenzierungsfaktoren und deren verwendung
|
|
US7572440B2
(en)
|
1999-07-30 |
2009-08-11 |
Stryker Corporation |
Method for repairing a defect in an intervertebral disc
|
|
US20030224501A1
(en)
|
2000-03-17 |
2003-12-04 |
Young Paul E. |
Bone morphogenic protein polynucleotides, polypeptides, and antibodies
|
|
US20030104977A1
(en)
|
2000-03-31 |
2003-06-05 |
Ugo Ripamonti |
Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
EP1790726B1
(en)
|
2001-02-08 |
2013-07-03 |
Wyeth LLC |
Modified and stabilized GDF propeptides and uses thereof
|
|
US20060078532A1
(en)
|
2004-10-12 |
2006-04-13 |
Omoigui Osemwota S |
Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease
|
|
US20070155661A1
(en)
*
|
2003-02-14 |
2007-07-05 |
The Board Of Trustees Of The Leland Standord Junior University |
Methods and compositions for modulating the development of stem cells
|
|
NZ529860A
(en)
|
2003-11-28 |
2006-10-27 |
Ovita Ltd |
Muscle growth regulator mighty and use in promoting muscle mass and treating muscle wasting diseases
|
|
US7388027B2
(en)
|
2004-03-04 |
2008-06-17 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
|
EP1733041B1
(en)
|
2004-03-23 |
2012-05-09 |
Eli Lilly & Company |
Anti-myostatin antibodies
|
|
DK2332977T3
(en)
|
2004-07-23 |
2016-02-29 |
Acceleron Pharma Inc |
ActRII receptor polypeptides
|
|
US20060216279A1
(en)
|
2005-03-22 |
2006-09-28 |
Glass David J |
Myostatin inhibiting fusion polypeptides and therapeutic methods thereof
|
|
EA201100642A1
(ru)
|
2005-04-25 |
2011-12-30 |
Пфайзер Инк. |
Антитела к миостатину
|
|
WO2006128190A2
(en)
|
2005-05-27 |
2006-11-30 |
The Regents Of The University Of California |
Compositions and methods for treatment of neural disorders using transforming growth factor-beta superfamily proteins and their antagonists
|
|
US7888486B2
(en)
|
2005-08-19 |
2011-02-15 |
Wyeth Llc |
Antagonist antibodies against GDF-8
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
WO2007109686A2
(en)
|
2006-03-20 |
2007-09-27 |
University Of Pittsburgh |
Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto
|
|
US20080044387A1
(en)
|
2006-03-24 |
2008-02-21 |
The Regents Of The University Of California |
Artificial niches for enhancement of regenerative capacity of stem cells in aged and pathological environments
|
|
US20090298761A1
(en)
|
2006-05-17 |
2009-12-03 |
Donald Engelman |
Methods of treating cartilage defects using a soluble morphogenic protein complex
|
|
US8168169B2
(en)
|
2006-08-09 |
2012-05-01 |
Mclean Hospital Corporation |
Methods and compositions for the treatment of medical disorders
|
|
TW201718635A
(zh)
|
2007-03-06 |
2017-06-01 |
安美基公司 |
變異之活動素受體多肽及其用途
|
|
US8404656B2
(en)
*
|
2007-08-09 |
2013-03-26 |
Children's Hospital Medical Center |
Methods of treatment and prevention of diet-induced obesity and sequelae thereof
|
|
EP2282755A4
(en)
|
2008-03-20 |
2015-06-17 |
Morphotek Inc |
INHIBITION OF ANGIOGENESIS
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
US8969081B2
(en)
|
2008-12-10 |
2015-03-03 |
The Trustees Of Columbia University In The City Of New York |
Caudal motor neuron derived from embryonic stem cells under conditions essentially free of any retinoid
|
|
KR101558642B1
(ko)
|
2009-02-24 |
2015-10-12 |
솔크 인스티튜트 포 바이올로지칼 스터디즈 |
Ｔｇｆ-베타 슈퍼패밀리의 설계자 리간드
|
|
US20130108645A1
(en)
|
2010-04-13 |
2013-05-02 |
The Johns Hopkins University |
Methods for enhancing axonal regeneration
|
|
US20140127329A1
(en)
|
2011-03-31 |
2014-05-08 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline
|
|
US8765385B2
(en)
*
|
2011-10-27 |
2014-07-01 |
Ravindra Kumar |
Method of detection of neutralizing anti-actriib antibodies
|
|
US9434779B2
(en)
|
2012-03-19 |
2016-09-06 |
The Brigham And Women's Hospital, Inc. |
Growth differentiation factor 11 (GDF-11) for treatment of diastolic heart failure
|
|
JP2016518357A
(ja)
|
2013-04-08 |
2016-06-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
骨格筋幹細胞を若返らせる方法および組成物
|
|
KR102390167B1
(ko)
*
|
2013-06-11 |
2022-04-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
SC-β 세포 및 조성물 그리고 그 생성 방법
|
|
EP3881859B1
(en)
|
2013-06-11 |
2024-03-06 |
President and Fellows of Harvard College |
Compositions for increasing neurogenesis and angiogenesis
|
|
ES2767050T3
(es)
|
2013-09-03 |
2020-06-16 |
Mayo Found Medical Education & Res |
Reducción del riesgo de eventos cardíacos adversos mayores
|
|
WO2015070076A2
(en)
|
2013-11-08 |
2015-05-14 |
President And Fellows Of Harvard College |
Methods and compositions for rejuvenating neuromuscular junctions
|
|
US10017566B2
(en)
|
2013-11-12 |
2018-07-10 |
The Brigham And Women's Hospital, Inc. |
Growth differentiation factor (GDF) for treatment of diastolic heart failure
|
|
US20170073406A1
(en)
|
2014-05-06 |
2017-03-16 |
Scholar Rock, Inc. |
Compositions and methods for growth factor modulation
|
|
US20170298128A1
(en)
|
2014-09-23 |
2017-10-19 |
President And Fellows Of Harvard College |
Methods and compositions for treating age-related disorders
|
|
CN116059320A
(zh)
|
2016-01-06 |
2023-05-05 |
哈佛学院校长同事会 |
使用gdf11的治疗防止体重增加、提高葡萄糖耐量并减轻脂肪肝
|
|
US10941195B2
(en)
|
2016-10-04 |
2021-03-09 |
Fairbanks Pharmaceuticals, Inc. |
Anti-follistatin-like 3 antibodies and treatment of diabetes
|
|
WO2019144053A1
(en)
|
2018-01-19 |
2019-07-25 |
President And Fellows Of Harward College |
Gdf11 variants and uses thereof
|